University of Texas Health Science Center: Oral Pill Slows Rate of Decline in ALS Patients
September 09, 2020
September 09, 2020
SAN ANTONIO, Texas, Sept. 9 (TNSJou) -- The University of Texas Health Science Center at San Antonio issued the following news release:
Although it's not a cure for ALS, an oral drug slowed patients' rate of functional decline in a clinical trial that included five patients at UT Health San Antonio. If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS.
The New England Journal of Medicine publish . . .
Although it's not a cure for ALS, an oral drug slowed patients' rate of functional decline in a clinical trial that included five patients at UT Health San Antonio. If the finding is repeated in larger trials, the drug could give families more time with their loved ones who have ALS.
The New England Journal of Medicine publish . . .